In response to tissue injury elicited by trauma or infection, the inflammatory response, as a complex network of molecular and cellular interactions, sets an answer directed to facilitate a return to physiological homeostasis and tissue repair. The role of the genetic background and the subsequent predisposition toward the extent of the inflammatory response is determined by gene variability encoding endogenous mediators involved in the inflammatory pathway. Due to its clinical relevance, the genetics of inflammation in aging will be studied using an inflammatory disease like atherosclerosis as an example. Several studies have reported a significant difference in distribution, between patients and controls, of genes involved in inflammation. So, the proinflammatory alleles are underrepresented in control subjects and overrepresented in patients affected by atherosclerosis. These studies will allow building a risk profile that potentially enables the early identification of individuals susceptible to disease and the possible design or use of drug at the right dose for a desired effect, that is, a pharmacogenomic approach for this disease.

GRIMALDI MP, VASTO S, BALISTRERI CR, DI CARLO D, CARUSO M, INCALCATERRA E, et al. (2007). Genetics of inflammation in age-related atherosclerosis: its relevance to pharmacogenomics. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1100, 123-131 [10.1196/annals.1395.010].

Genetics of inflammation in age-related atherosclerosis: its relevance to pharmacogenomics.

GRIMALDI, Maria Paola;VASTO, Sonya;BALISTRERI, Carmela Rita;DI CARLO, Daniele;INCALCATERRA, Egle;LIO, Domenico;CARUSO, Calogero;CANDORE, Giuseppina
2007-01-01

Abstract

In response to tissue injury elicited by trauma or infection, the inflammatory response, as a complex network of molecular and cellular interactions, sets an answer directed to facilitate a return to physiological homeostasis and tissue repair. The role of the genetic background and the subsequent predisposition toward the extent of the inflammatory response is determined by gene variability encoding endogenous mediators involved in the inflammatory pathway. Due to its clinical relevance, the genetics of inflammation in aging will be studied using an inflammatory disease like atherosclerosis as an example. Several studies have reported a significant difference in distribution, between patients and controls, of genes involved in inflammation. So, the proinflammatory alleles are underrepresented in control subjects and overrepresented in patients affected by atherosclerosis. These studies will allow building a risk profile that potentially enables the early identification of individuals susceptible to disease and the possible design or use of drug at the right dose for a desired effect, that is, a pharmacogenomic approach for this disease.
Settore MED/04 - Patologia Generale
GRIMALDI MP, VASTO S, BALISTRERI CR, DI CARLO D, CARUSO M, INCALCATERRA E, et al. (2007). Genetics of inflammation in age-related atherosclerosis: its relevance to pharmacogenomics. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1100, 123-131 [10.1196/annals.1395.010].
File in questo prodotto:
File Dimensione Formato  
GRIMALDI_et_al-2007-Annals_of_the_New_York_Academy_of_Sciences (2).pdf

Solo gestori archvio

Descrizione: pdf articolo
Dimensione 68.07 kB
Formato Adobe PDF
68.07 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/9213
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 11
social impact